Mirae Asset Global Investments Co., Ltd. Procept Bio Robotics Corp Transaction History

Mirae Asset Global Investments Co., Ltd.

$24 Billion
Q4 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 8,056 shares of PRCT stock, worth $560,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,056

Previous 8,220 2.0%

Holding current value

$560,375

Previous $658,000 1.52%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$67.27 - $99.45 $11,032 - $16,309	-164 Reduced 2.0%	8,056 $648,000
Q3 2024 Oct 23, 2024	SELL	$56.31 - $84.99 $31,195 - $47,084	-554 Reduced 6.31%	8,220 $658,000
Q2 2024 Jul 30, 2024	SELL	$45.73 - $69.19 $17.6 Million - $26.6 Million	-384,766 Reduced 97.77%	8,774 $536,000
Q1 2024 May 01, 2024	SELL	$40.38 - $50.75 $4.4 Million - $5.53 Million	-109,063 Reduced 21.7%	393,540 $19.4 Million
Q4 2023 Jan 24, 2024	BUY	$24.89 - $43.41 $103,393 - $180,325	4,154 Added 0.83%	502,603 $21.1 Million
Q3 2023 Oct 26, 2023	SELL	$30.02 - $38.81 $73,158 - $94,579	-2,437 Reduced 0.49%	498,449 $16.4 Million
Q2 2023 Aug 10, 2023	BUY	$26.7 - $37.02 $3.11 Million - $4.32 Million	116,664 Added 30.36%	500,886 $17.7 Million
Q1 2023 May 04, 2023	BUY	$26.64 - $39.74 $2.09 Million - $3.11 Million	78,298 Added 25.59%	384,222 $10.9 Million
Q4 2022 Feb 09, 2023	SELL	$38.78 - $46.78 $559,672 - $675,128	-14,432 Reduced 4.5%	305,924 $12.7 Million
Q3 2022 Nov 10, 2022	BUY	$30.9 - $50.65 $9.47 Million - $15.5 Million	306,389 Added 2193.66%	320,356 $13.3 Million
Q2 2022 Jul 26, 2022	BUY	$29.23 - $44.45 $408,255 - $620,833	13,967 New	13,967 $456,000

Others Institutions Holding PRCT

# of Institutions

277

Shares Held

39.5M

Call Options Held

262K

Put Options Held

257K

View Full List

About PROCEPT BioRobotics Corp

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $3.1B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

More about PRCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Procept Bio Robotics Corp Transaction History